CD4 and neoplasm: Furthermore, tEV plus SyBV treatment stimulated tEV antigen‐specific CTL responses with an increase in IFN‐γ (Figure 5l, m), which is considered to be more essential than the role of CD4+ T cells for the substantive killing of tumour cells (Farhood et al., 2019).